|
Jul 24
|
Virpax Regains Compliance with Nasdaq Minimum Bid Price
|
|
Dec 29
|
Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
|
|
Apr 27
|
Virpax Pharmaceuticals Engages Dr. Pardeep Gupta to Assist in Development of Company’s Lead Asset, Probudur™
|